Guidelines for diagnosis, treatment and monitoring of primary immune thrombocytopenia;Diagnóstico, tratamiento y seguimiento de la trombocitopenia inmune primaria

Medicina Clinica

Volumn 138, Issue 6, 2012, Pages

  Sanz, Miguel Ángel ^a   Vicente García, Vicente ^b   Fernández, Antonio ^c   López, M Fernanda ^d   Grande, Carlos ^e   Jarque, Isidro ^a   Martínez, Rafael ^f   Mingot, María Eva ^g   Monteagudo, Emilio ^a   Ribera, Josep M ^h   Valcárcel, David ⁱ  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b HOSPITAL MORALES MESEGUER   (Spain)

^c HOSPITAL JUAN RAMÓN JIMÉNEZ   (Spain)

^d HOSPITAL JUAN CANALEJO   (Spain)

^e HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^f HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^g HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^h HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

ⁱ HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Corticosteroids; Intravenous immunoglobulin; Primary immune thrombocytopenia; Splenectomy

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN;

BLEEDING; BLOOD CELL COUNT; CONFERENCE PAPER; CONSENSUS; HUMAN; PRACTICE GUIDELINE; PREGNANCY; PRIMARY IMMUNE THROMBOCYTOPENIA; REMISSION; SPLENECTOMY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT REFUSAL;

AGED; BENZOIC ACIDS; CHILD; FEMALE; GLUCOCORTICOIDS; HUMANS; HYDRAZINES; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; PYRAZOLES; QUALITY OF LIFE; RECEPTORS, FC; RECEPTORS, THROMBOPOIETIN; RECOMBINANT FUSION PROTEINS; SPLENECTOMY; THROMBOPOIETIN;

EID: 84857789700     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2011.11.011     Document Type: Conference Paper

References (51)

1. D.B. Cines, and J.B. Bussel How I treat idiopathic thrombocytopenic purpura (ITP) Blood 106 2005 2244 2251 (Pubitemid 41510792)
2. D. Provan, R. Stasi, A.C. Newland, V.S. Blanchette, P. Bolton-Maggs, and J.B. Bussel International consensus report on the investigation and management of primary immune thrombocytopenia Blood 115 2010 168 186
3. F. Rodeghiero, R. Stasi, T. Gernsheimer, M. Michel, D. Provan, and D.M. Arnold Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group Blood 113 2009 2386 2393
4. D.B. Cines, J.B. Bussel, H.A. Liebman, and E.T. Luning Prak The ITP syndrome: pathogenic and clinical diversity Blood 113 2009 6511 6521
5. R. Stasi, A. Sarpatwari, J.B. Segal, J. Osborn, M.L. Evangelista, and N. Cooper Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review Blood 113 2009 1231 1240
6. Y.C. Cohen, B. Djulbegovic, O. Shamai-Lubovitz, and B. Mozes The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts Arch Intern Med 160 2000 1630 1638 (Pubitemid 30367902)
7. J.E. Portielje, R.G. Westendorp, H.C. Kluin-Nelemans, and A. Brand Morbidity and mortality in adults with idiopathic thrombocytopenic purpura Blood 97 2001 2549 2554
8. M.G. Mazzucconi, P. Fazi, S. Bernasconi, G. De Rossi, G. Leone, and L. Gugliotta Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience Blood 109 2007 1401 1407 (Pubitemid 46239570)
9. W. Praituan, and P. Rojnuckarin Faster platelet recovery by high-dose dexamethasone compared with standard-dose prednisolone in adult immune thrombocytopenia: a prospective randomized trial J Thromb Haemost 7 2009 1036 1038
10. K. Kojouri, S.K. Vesely, D.R. Terrell, and J.N. George Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications Blood 104 2004 2623 2634 (Pubitemid 39434940)
11. N. Vianelli, M. Galli, A. de Vivo, T. Intermesoli, B. Giannini, and M.G. Mazzucconi Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases Haematologica 90 2005 72 77 (Pubitemid 40193756)
12. B. Habermalz, S. Sauerland, G. Decker, B. Delaitre, J.F. Gigot, and E. Leandros Laparoscopic splenectomy: the clinical practice guidelines of the European Association for Endoscopic Surgery (EAES) Surg Endosc 22 2008 821 848
13. J.M. Davies, R. Barnes, and D. Milligan Update of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen Clin Med 2 2002 440 443 (Pubitemid 35397712)
14. A.J. Lammers, D. Veninga, M.J. Lombarts, J.B. Hoekstra, and P. Speelman Management of post-splenectomy patients in the Netherlands Eur J Clin Microbiol Infect Dis 29 2010 399 405
15. J.A. Lamsfus-Prieto, E. Membrilla-Fernández, and J.M. Garcés-Jarque Prevención de la sepsis en pacientes esplenectomizados Cir Esp 81 2007 247 251
16. B. Godeau, D. Provan, and J. Bussel Immune thrombocytopenic purpura in adults Curr Opin Hematol 14 2007 535 556 (Pubitemid 47457646)
17. J.B. Bussel, D.J. Kuter, V. Pullarkat, R.M. Lyons, M. Guo, and J.L. Nichol Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP Blood 113 2009 2161 2171
18. D.J. Kuter, M. Rummel, R. Boccia, B.G. Macik, I. Pabinger, and D. Selleslag Romiplostim or standard of care in patients with immune thrombocytopenia N Engl J Med 363 2010 1889 1899
19. ® (romiplostim). Ficha técnica. [consultado 28/12/2011]. Disponible en: http://www.ema.europa.eu/docs/es-ES/document- library/EPAR-Product-Information/human/000942/WC500039537.pdf
20. J.B. Bussel, D. Provan, T. Shamsi, G. Cheng, B. Psaila, and L. Kovaleva Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial Lancet 373 2009 641 648
21. ® (eltrombopag). Ficha técnica. [consultado 28/12/2011]. Disponible en: http://www.ema.europa.eu/docs/es-ES/document- library/EPAR-Product-Information/human/001110/WC500089964.pdf
22. B. Psaila, and J.B. Bussel Refractory immune thrombocytopenic purpura: current strategies for investigation and management Br J Haematol 143 2008 16 26
23. D.M. Arnold, F. Dentali, M.A. Crowther, R.M. Meyer, R.J. Cook, and C. Sigouin Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura Ann Intern Med 146 2007 25 33 (Pubitemid 351650318)
24. F.J. García Hernández, C. Ocaña Medina, R. González León, R. Garrido Rasco, R. Colorado Bonilla, and M.J. Castillo Palma Utilidad del rituximab en el tratamiento de pacientes con enfermedades sistémicas autoinmunitarias Med Clin (Barc) 128 2007 458 462
25. J.L. Callejas Rubio, M.T. Camps, and F. García-Hernández Rituximab en el tratamiento de enfermedades autoinmunitarias: resultados del registro de la Asociación Andaluza de Enfermedades Autoinmunes Med Clin (Barc) 130 2008 79 (Pubitemid 351303055)
26. F. Zaja, M.L. Battista, M.T. Pirrotta, S. Palmieri, M. Montagna, and N. Vianelli Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura Haematologica 93 2008 930
27. F. Zaja, N. Vianelli, S. Volpetti, M.L. Battista, M. Defina, and S. Palmieri Low dose rituximab in adult patients with primary immune thrombocytopenia Eur J Haematol 85 2010 329 334
28. B. Godeau, R. Porcher, O. Fain, F. Lefrere, P. Fenaux, and S. Cheze Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study Blood 112 2008 999 1004
29. F. Zaja, M. Baccarani, P. Mazza, M. Bocchia, L. Gugliotta, and A. Zaccaria Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia Blood 115 2010 2755 2762
30. J. Burzynski New options after first-line therapy for chronic immune thrombocytopenic purpura Am J Health Syst Pharm 66 2009 S11 S21
31. D.M. Boruchov, S. Gururangan, M.C. Driscoll, and J.B. Bussel Multiagent induction and maintenance therapy for patients with refractory immune thrombocytopenic purpura (ITP) Blood 110 2007 3526 3531 (Pubitemid 350159616)
32. F. Willis, J.C. Marsh, D.H. Bevan, S.B. Killick, G. Lucas, and R. Griffiths The effect of treatment with Campath-1H in patients with autoimmune cytopenias Br J Haematol 114 2001 891 898 (Pubitemid 32953751)
33. J.R. Passweg, and M. Rabusin Hematopoetic stem cell transplantation for immune thrombocytopenia and other refractory autoimmune cytopenias Autoimmunity 41 2008 660 665
34. E. Monteagudo, R. Fernández-Delgado, A. Sastre, T. Toll, A. Llort, and J. Molina Protocolo de estudio y tratamiento de la trombocitopenia inmune primaria (PTI-2010) An Pediatr 74 2011 414.e1 414.e8
35. K.R. McCrae Thrombocytopenia in pregnancy: differential diagnosis, pathogenesis, and management Blood Rev 17 2003 7 14 (Pubitemid 36176207)
36. T. Gernsheimer, and K.R. McCrae Immune thrombocytopenic purpura in pregnancy Curr Opin Hematol 14 2007 574 580 (Pubitemid 47457648)
37. K.E. Webert, R. Mittal, C. Sigouin, N.M. Heddle, and J.G. Kelton A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura Blood 102 2003 4306 4311 (Pubitemid 37494088)
38. E. Stavrou, and K.R. McCrae Immune thrombocytopenia in pregnancy Hematol Oncol Clin North Am 23 2009 1299 1316
39. A.J. Marti-Carvajal, G.E. Pena-Marti, and G. Comunian-Carrasco Medical treatments for idiopathic thrombocytopenic purpura during pregnancy Cochrane Database Syst Rev 2009 CD007722
40. J.E. Spahr, and G.M. Rodgers Treatment of immune-mediated thrombocytopenia purpura with concurrent intravenous immunoglobulin and platelet transfusion: a retrospective review of 40 patients Am J Hematol 83 2008 122 125
41. L. Bizzoni, M.G. Mazzucconi, M. Gentile, C. Santoro, S. Bernasconi, and F. Chiarotti Idiopathic thrombocytopenic purpura (ITP) in the elderly: clinical course in 178 patients Eur J Haematol 76 2006 210 216
42. S. Daou, L. Federici, J. Zimmer, F. Maloisel, K. Serraj, and E. Andres Idiopathic thrombocytopenic purpura in elderly patients: a study of 47 cases from a single reference center Eur J Intern Med 19 2008 447 451
43. M.G. Sarkiss, S.W. Yusuf, C.L. Warneke, G. Botz, N. Lakkis, and C. Hirch-Ginsburg Impact of aspirin therapy in cancer patients with thrombocytopenia and acute coronary syndromes Cancer 109 2007 621 627 (Pubitemid 46190972)
44. K. Tousovska, O. Zapletal, J. Skotakova, J. Bukac, and J. Sterba Treatment of deep venous thrombosis with low molecular weight heparin in pediatric cancer patients: safety and efficacy Blood Coagul Fibrinolysis 20 2009 583 589
45. S. Choi, and R. Brull Neuraxial techniques in obstetric and non-obstetric patients with common bleeding diatheses Anesth Analg 109 2009 648 660
46. M. Franchini, M. Cruciani, C. Mengoli, G. Pizzolo, and D. Veneri Effect of Helicobacter pylori eradication on platelet count in idiopathic thrombocytopenic purpura: a systematic review and meta-analysis J Antimicrob Chemother 60 2007 237 246 (Pubitemid 47243869)
47. H.A. Liebman, and R. Stasi Secondary immune thrombocytopenic purpura Curr Opin Hematol 14 2007 557 573 (Pubitemid 47457647)
48. S.K. Rajan, B.M. Espina, and H.A. Liebman Hepatitis C virus-related thrombocytopenia: clinical and laboratory characteristics compared with chronic immune thrombocytopenic purpura Br J Haematol 129 2005 818 824 (Pubitemid 40904534)
49. I.B. Sundell, and P.S. Koka Thrombocytopenia in HIV infection: impairment of platelet formation and loss correlates with increased c-Mpl and ligand thrombopoietin expression Curr HIV Res 4 2006 107 116
50. I. Jarque, R. Andreu, I. Llopis, J. de la Rubia, F. Gomis, and L. Senent Absence of platelet response after eradication of Helicobacter pylori infection in patients with chronic idiopathic thrombocytopenic purpura Br J Haematol 115 2001 1002 1003 (Pubitemid 34042923)
51. R. Hoffman, B. Furie, E.J. Benz, P. McGlave, L.E. Silberstein, and S.J. Shattil Hematology: basic principles and practice 2009 Churchill Livingstone/Elsevier Philadelphia